SBFM Q4 2016 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$68,138+4089.3% YoY

Gross Profit

$34,06950.0% margin

Operating Income

-$336,097-493.3% margin

Net Income

-$1M-1650.3% margin

EPS (Diluted)

$-27.92

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$31,194

Free Cash Flow

-$32,290

Stock-Based Comp.

$702,300

Balance Sheet

Total Assets

$64,404

Total Liabilities

$274,104

Stockholders' Equity

-$209,700

Cash & Equivalents

$57,453

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68,138	-$1,708	+4089.3%
Gross Profit	$34,069	-$127,194	+126.8%
Operating Income	-$336,097	-$174,242	-92.9%
Net Income	-$1M	-$647,679	-73.6%